Literature DB >> 17380558

NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage.

M T Chiriac1, J Roesler, A Sindrilaru, K Scharffetter-Kochanek, D Zillikens, C Sitaru.   

Abstract

The contribution of phagocyte-derived reactive oxygen species to tissue injury in autoimmune inflammatory diseases is unclear. Here we report that granulocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase crucially contributes to tissue injury in experimental models of the antibody-mediated autoimmune disease epidermolysis bullosa acquisita. Neutrophil cytosolic factor 1-deficient mice lacking functional NADPH oxidase were resistant to skin blistering by the passive transfer of antibodies against type VII collagen. Pharmacological inhibition or deficiency of human NADPH oxidase abolished dermal-epidermal separation caused by autoantibodies and granulocytes ex vivo. In addition, recruitment of granulocytes into the skin was required for tissue injury, as demonstrated by the resistance to experimental blistering of wild-type mice depleted of neutrophils and of CD18-deficient mice. Transfer of neutrophil cytosolic factor 1-sufficient granulocytes into neutrophil cytosolic factor 1-deficient mice demonstrated that granulocytes provide the NADPH oxidase required for tissue damage. Our findings identify granulocyte-derived NADPH oxidase as a key molecular effector engaged by pathogenic autoantibodies and provide relevant targets for prevention of tissue damage in granulocyte-mediated autoimmune diseases. Copyright (c) 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380558     DOI: 10.1002/path.2157

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  32 in total

Review 1.  Mechanisms and consequences of neutrophil interaction with the endothelium.

Authors:  Alexander Zarbock; Klaus Ley
Journal:  Am J Pathol       Date:  2007-12-13       Impact factor: 4.307

2.  Granulocyte-dependent autoantibody-induced skin blistering.

Authors:  Kinga Csorba; Sebastian Sitaru; Cassian Sitaru
Journal:  J Vis Exp       Date:  2012-10-12       Impact factor: 1.355

Review 3.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

4.  Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters.

Authors:  Artem Vorobyev; Hideyuki Ujiie; Andreas Recke; Jacqueline J A Buijsrogge; Marcel F Jonkman; Hendri H Pas; Hiroaki Iwata; Takashi Hashimoto; Soo-Chan Kim; Jong Hoon Kim; Richard Groves; Unni Samavedam; Yask Gupta; Enno Schmidt; Detlef Zillikens; Hiroshi Shimizu; Ralf J Ludwig
Journal:  J Invest Dermatol       Date:  2015-02-17       Impact factor: 8.551

5.  Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita.

Authors:  Misa Hirose; Benjamin Tiburzy; Norito Ishii; Elena Pipi; Sabina Wende; Ellen Rentz; Falk Nimmerjahn; Detlef Zillikens; Rudolf A Manz; Ralf J Ludwig; Michael Kasperkiewicz
Journal:  J Invest Dermatol       Date:  2014-10-20       Impact factor: 8.551

6.  Dual inhibition of complement factor 5 and leukotriene B4 synergistically suppresses murine pemphigoid disease.

Authors:  Tanya Sezin; Sripriya Murthy; Claudia Attah; Malte Seutter; Maike M Holtsche; Christoph M Hammers; Enno Schmidt; Fibi Meshrkey; Sadegh Mousavi; Detlef Zillikens; Miles A Nunn; Christian D Sadik
Journal:  JCI Insight       Date:  2019-08-08

7.  Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment.

Authors:  Misa Hirose; Anika Kasprick; Foteini Beltsiou; Katharina Dieckhoff Schulze; Franziska Sophine Schulze; Unni Kjsrl Samavedam; Jennifer E Hundt; Hendri H Pas; Marcel F Jonkman; Enno Schmidt; Kathrin Kalies; Detlef Zillikens; Ralf J Ludwig; Katja Bieber
Journal:  Mol Med       Date:  2016-12-20       Impact factor: 6.354

8.  Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII.

Authors:  Kinga Csorba; Alina Sesarman; Eva Oswald; Vasile Feldrihan; Anja Fritsch; Takashi Hashimoto; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-01-20       Impact factor: 9.261

Review 9.  Neutrophils in animal models of autoimmune disease.

Authors:  Tamás Németh; Attila Mócsai; Clifford A Lowell
Journal:  Semin Immunol       Date:  2016-04-07       Impact factor: 11.130

10.  Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita.

Authors:  Alina Sesarman; Ana Gabriela Sitaru; Florina Olaru; Detlef Zillikens; Cassian Sitaru
Journal:  J Mol Med (Berl)       Date:  2008-06-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.